According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

A third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...

PanACEA是针对结核病药物开展的首批基于适应性模型的剂量发现研究之一，也是在非洲开展的首个此类研究，这项研究的创新性设计包括对食物效应和其与药物之间的相互作用进行评估，从而就能帮助更好地理解BTZ-043的最佳 管理 手段。

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

HealthDay News — In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine, updated ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

NHSO approves six new drugs for insurance, enhancing treatments for tuberculosis, hepatitis C, and lymphoma, saving millions ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...